Chemours Swings to Loss on Cyclical Headwinds, Announces Kuan Yin Site Sale
Event summary
- Chemours reported a net loss of $386 million, or $2.57 per diluted share, in 2025, compared to a net income of $69 million the prior year.
- The company sold its Kuan Yin TiO2 site for approximately $3004 million in net proceeds, expected to boost cash inflow in 2026.
- Adjusted EBITDA decreased to $742 million in 2025, down from $768 million in 2024, due to cyclical headwinds in the Advanced Performance Materials (APM) business and lower Titanium Technologies (TT) pricing.
- TSS (Thermal & Specialized Solutions) reported record annual sales with double-digit growth in Opteon™ Refrigerants, offsetting weakness in other segments.
The big picture
Chemours' 2025 results highlight the vulnerability of specialty chemical companies to cyclical end markets, particularly those reliant on industrial demand. The sale of the Kuan Yin TiO2 site signals a strategic shift towards prioritizing cash flow and debt reduction, potentially at the expense of long-term growth initiatives. The company's performance is increasingly tied to the success of its Opteon™ refrigerant transition and its ability to navigate evolving regulatory landscapes.
What we're watching
- Market Recovery
- Whether the cyclical headwinds impacting the APM business will abate and allow for a rebound in performance, or if Chemours will need to further prioritize cash flow over growth.
- Pricing Power
- How effectively Chemours can sustain the TiO2 price increases implemented in December 2025, given ongoing competitive pressures and potential shifts in demand.
- Debt Profile
- The company’s ability to utilize the proceeds from the Kuan Yin site sale to meaningfully reduce its debt and improve its leverage ratio, bringing it closer to its target of below three times adjusted EBITDA.
Related topics